A recent report published by
Infinium Global Research on epilepsy drug market provides in-depth analysis of
segments and sub-segments in the global as well as regional epilepsy drug
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional epilepsy drug market over the short term
as well as long term. The report is a comprehensive presentation of trends,
forecast and dollar values of the global epilepsy drug market. According to the
report, the global epilepsy drug market is projected to grow at a CAGR of 7.1%
over the forecast period of 2019-2025.
Epilepsy is a neurological
disorder in which brain activity becomes abnormal, causing seizures or periods
of unusual behavior, sensations, and sometimes loss of awareness. It occurs in
both sexes, at all ages, particularly in childhood and an increase in aging
populations. Moreover, the most common type of epilepsy is idiopathic epilepsy
and has no identifiable cause. This brain disorder is usually treated by
medication and in some cases by implantable devices, surgery, and dietary
changes.
Growing prevalence’s of
neurological disorders, growth in roadside accidents and rising occurrences of
epilepsy across the globe are some factors driving the growth of epilepsy drug
market. As per the World Health Organization, it is estimated that around 50 million
patients are living with epilepsy and about 2.4 million people are diagnosed
with epilepsy each year. Furthermore, anti-epilepsy drugs Epidiolex approvals
for pediatric epilepsies is another factor help in the growth of the epilepsy drug
market. Additionally, growing awareness about epilepsy among the people,
increasing government funding and drugs reimbursement options are further
expected to fuel the market growth. However, less awareness regarding epilepsy
drug in middle-income economies is likely to restraints the growth of epilepsy
drug market. Going further, growing R&D investment and number of
manufacturers are more focusing on developing the greatly effective and safe
medicines to control seizures in patients suffering from epilepsy disorder are
creating growth opportunities for the growth of epilepsy drug market.
Geographically, North America is
expected to hold maximum share in the epilepsy drug market. The factors such as
increased investment in the R&D, presence of favorable government initiatives
and new product development are responsible for the growth of the market in the
North America region. According to data released by CDC’s, the number of U.S.
children and adults with epilepsy are growing, with at least 3.4 million people
living with epilepsy disorder. Epilepsy is more common in developing countries
than in developed ones. Moreover, Asia Pacific is anticipated to witness the
highest growth rate during the forecast period. The growth of this region is
attributed due to growing awareness regarding epilepsy drug and increasing
incidences of brain injuries.
The report on global epilepsy drug
market covers segments such as product type. On the basis of product type, the
sub-markets include first-generation drugs, second-generation drugs, and third
generation drugs.
The report provides profiles of
the companies in the market such as Teva Pharmaceutical Industries Ltd., Sunovion
Pharmaceuticals, Inc., GlaxoSmithKline plc, Abbott Laboratories, Sanofi S.A.,
Novartis International AG, Eisai Co., Ltd., Pfizer Inc., UCB S.A., and Johnson
& Johnson.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of epilepsy drug market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.
Please Choose One of them.